Datar Cancer Genetics Unveils AI-Driven Video-Based Chemotherapy Testing
The video-reporting service for in-vitro chemosensitivity testing uses real-time visual evidence to assess chemotherapy drug effectiveness.
Read MorePosted by Andy Lundin | Jan 28, 2025 | Cancer |
The video-reporting service for in-vitro chemosensitivity testing uses real-time visual evidence to assess chemotherapy drug effectiveness.
Read MorePosted by Andy Lundin | Jan 24, 2025 | Sequencing Systems |
Researchers demonstrate the potential of long-read sequencing to diagnose rare genetic diseases faster and more accurately.
Read MorePosted by Andy Lundin | Jan 21, 2025 | Prostate |
A review found gaps remain for genomic classifier tests for their cost-effectiveness, clinical utility, and impact on diverse populations.
Read MorePosted by Andy Lundin | Jan 20, 2025 | Molecular Diagnostics |
Avalon Healthcare Solutions expanded its partnership with Sentara Health Plans for evidence-based genetic testing management services.
Read MorePosted by Andy Lundin | Jan 16, 2025 | Lymphoma, Molecular Diagnostics |
Foresight Diagnostics’ ctDNA-MRD testing has been included in the NCCN Clinical Practice Guidelines for diffuse large B-cell lymphoma.
Read More